Vale González
Carmen Vale González, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20120245223 | USE OF GYMNODIMINE, ANALOGUES AND DERIVATIVES FOR THE TREATMENT AND/OR PREVENTION OF NEURODEGENERATIVE DISEASES ASSOCIATED WITH TAU AND B-AMYLOID - The present invention refers to the use of a compound with the chemical structure | 09-27-2012 |
20120258956 | USE OF A SPIROLIDE, ANALOGUES AND DERIVATIVES FOR TREATING AND/OR PREVENTING PATHOLOGICAL CONDITIONS LINKED TO THE TAU AND BETA-AMYLOID PROTEINS - The present invention is in the field of biomedicine. Specifically, it relates to the use of a spirolide compound with the chemical structure: | 10-11-2012 |
20130035302 | USE OF YESSOTOXIN AND ANALOGUES AND DERIVATIVES THEREOF FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE DISEASES LINKED TO TAU AND BETA AMYLOID - The present invention is in the field of biomedicine pharmaceutical chemistry. Specifically, it refers to the use of yessotoxin, its derivatives and analogues, for the preparation of a medicinal drug for the prevention and/or treatment of neurodegenerative diseases related to abnormal levels of Tau and β-amyloid proteins such as, for example, Alzheimer's disease. | 02-07-2013 |
Carmen Vale González, Santiago De Compostela ( A Coruna) ES
Patent application number | Description | Published |
---|---|---|
20120283321 | USE OF GAMBIEROL FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE DISEASES RELATED TO TAU AND BETA-AMYLOID - The present invention relates to the use of a compound with the following chemical structure: | 11-08-2012 |
Carmen Vale González, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20130035302 | USE OF YESSOTOXIN AND ANALOGUES AND DERIVATIVES THEREOF FOR TREATING AND/OR PREVENTING NEURODEGENERATIVE DISEASES LINKED TO TAU AND BETA AMYLOID - The present invention is in the field of biomedicine pharmaceutical chemistry. Specifically, it refers to the use of yessotoxin, its derivatives and analogues, for the preparation of a medicinal drug for the prevention and/or treatment of neurodegenerative diseases related to abnormal levels of Tau and β-amyloid proteins such as, for example, Alzheimer's disease. | 02-07-2013 |